Kazia Therapeutics Limited - ADR Live Stock Price Today, Share Analysis and Chart

Name: Kazia Therapeutics Limited - ADR: Is Infosys Ltd. worth buying?
Item: Kazia Therapeutics Limited - ADR
Rating: 1.39575
Author: Trendlyne DVM scores

about

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. ...

8.10 0.34 (4.38%)

79.26% Fall from 52W High

3,288

XNAS Volume

XNAS 08 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

55.8 / 100

1Yr Price target upside is 74%

2 analysts

Kazia Therapeutics Limited... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..